HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY OF ARGININE CONTAINING BEARBERRY LEAVES EXTRACT IN INSULIN RESISTANT RATS
Introduction. In recent decades, diabetes mellitus type 2 (DM2) has become one of the leading causes of deaths worldwide. A number of studies confirmed the causal relationship between the development of insulin resistance (IR) and DM2. At the same time, traditionally and for many years the plants or substances isolated from them have been using in the DM2 treatment and correction of its complications.
The aim of the study – to find out the effect of ethanolic polyphenol Bearberry leaves (Arctostaphylos uva-ursi) extract enriched with arginine (PE50_arg) on tolerance to glucose and lipid metabolism under experimental IR in rats.
Research Methods. Adult male outbred albino rats were used in the present study. Two experimental IR models were conducted: daily intraperitoneal administration of dexamethasone and a diet enriched with fructose. Treating was performed by oral administration of polyphenolic alcohol extract (PE50) and the corresponding extract with the addition of arginine (PE50_arg). IR was confirmed by measuring immunoreactive insulin (IRI) and plasma glucose levels. At the end of the experiment, the lipid profile was investigated in the obtained serum samples. The statistical processing of the data was carried out using the STATISTICA program (StatSoftInc., USA, version 6.0).
Results and Discussion. A diet for 7 weeks enriched with fructose caused IR in rats. Also we observed increased triacylglycerol (TAG), free fatty acids (FFA) and cholesterol (Ch) levels. Daily injections of dexamethasone, which maintained the hormone level for 5 weeks, led to the IR development. Under hormone-induced IR also FFA and TAG levels were elevated, but Ch concentration in blood plasma did not significantly change. Both extracts, PE50 and PE50_arg, improve cell sensitivity to insulin in experimental IR models. At the same time, PE50_arg has a more pronounced normalizing effect on the lipid parameters being investigated.
Conclusions. Our results suggest that PE50_arg may be a potentially promising anti-diabetic agent.
Khan, M.A.B., Hashim, M.J., King, J., Govender, R.D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes. Global Burden of Disease and Forecasted Trends Journal of Epidemiology and Global Health, 10, 107-111.
Cho, N.H., Shaw, J.E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A.W., & Malanda, B. (2019). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281.
Yaribeygi, H., Farrokhi, F.R., Butler, A.E., & Sahebkar, A. (2019) Insulin resistance: Review of the underlying molecular mechanisms. Journal of Cellular Physiology, 234, 8152-8161.
Petersen, M.C., & Shulman, G.I. (2018). Mechanisms of insulin action and insulin resistance. Physiological Reviews, 98, 2133-2223.
Bjornstad, P., & Eckel, R.H. (2018). Pathogenesis of lipid disorders in insulin resistance: A brief review. Current Diabetic Reports, 18, 127.
Spiller, S., Blüher, M., & Hoffmann, R. (2018) Plasma levels of free fatty acids correlate with type 2 diabetes mellitus diabetes, obesity and metabolism. A Journal of Pharmacology and Therapeutics, 20, 2661-2669.
Al-Snafi, A.E., Majid, W.J., & Talab, T.A. (2019) Medicinal plants with antidiabetic effects – an overview. IOSR Journal of Pharmacy, 9, 9-46.
Kravchenko, G., Mazen, M., & Krasilnikova, O. (2018). Screening of Bearberry leaves extracts hypoglycemic effect and study of acute toxicity. Ukrainskyi Biofarmacevtychnyj Journal, 2, 13-16.
Hu, S., Han, M., Rezaei, A., Li, D., Wu, G., & Ma, X. (2017). L-arginine modulates glucose and lipid metabolism in obesity and diabetes. Current Protein & Peptide Science, 18, 599-608.
Zahaiko, A.L., Briukhanova, T.O., & Shkapo, A.I. (2015). Modyfіkatsіia metodu modeliuvannia eksperymentalnoi іnsulіnorezystentostі u shchurіv: Іnformatsіinyi lyst Ukrmedpatentіnformu pro novovvedennia v systemi Okhorony Zdorovia [Modification of the experimental insulin resistance simulation method in rats: Ukrmedpatent Information Sheet on Innovation in Healthcare System No. 86-2015]. No. 86-2015, Kyiv [in Ukrainian].
Zagayko, A.L., Krasіlnіkova, O.A., Kravchenko, G.B., & Kochubey, Y.I. (2017). Vyvchennia hepatoprotektornoi aktyvnostі roslyn polіfenolіv na modelі eksperymentalnoi іnsulіnorezystentnostі [Study of hepatoprotective activity of plant polyphenols on a model of experimental insulin resistance]. Svit bіolohіi ta medytsyny – World of Biology and Medicine, 59, 117-121 [in Ukrainian].
Tran, L.T. Yuen, V.G., & McNeill, J.H. (2009). The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Molecular and Cellular Biochemistry, 332, 145-59.
Czech, M.P. (2017) Insulin action and resistance in obesity and type 2 diabetes. Nature Medicine, 23, 804-814.
Geer, E.B., Islam, J., & Buettner, C. (2014). Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinology and Metabolism Clinics of North America, 43, 75-102.
Luo, K., Chen, P., Li, S., Li, W., He, M., Wang, T., & Chen, J. (2017). Effect of L-arginine supplementation on the hepatic phosphatidiylinositol 3 kinase signaling pathway and gluconeogenic enzymes in early intrauterine growth-restricted rats. Experimental and Therapeutic Medicine, 14, 2355-2360.
Sears, B., Perry, M. (2015) The role of fatty acids in insulin resistance. Lipids in Health and Disease, 14, 121.
Tan, B., Li, X., Yin, Y., Wu, Z., Liu, C., Tekwe, C.D., Wu G. (2012) Regulatory roles for L-arginine in reducing white adipose tissue. Frontiers in Bioscience, 17, 2237-2246.